EUVIMEDEUVIMED entdecken
Editorial

Who benefits most from clinical artificial intelligence (AI)? Lessons from AI-assisted acute kidney injury prediction

Hae-Ryong Yun, Tae-Hyun Yoo

Kidney Research and Clinical Practice · 30.10.2026

DOI: 10.23876/j.krcp.26.384 ↗

Kurz gefasst

Editorial in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 30.10.2026. Verfasst von Hae-Ryong Yun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei Institute for Digital Healthcare, Yonsei University, Seoul, Republic of Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Yonsei Institute for Digital Healthcare, Yonsei University, Seoul, Republic of Korea.
  • Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Republic of Korea. yoosy0316@yuhs.ac.

Zitieren

APA

Yun, H. R., & Yoo, T. H. (2026). Who benefits most from clinical artificial intelligence (AI)? Lessons from AI-assisted acute kidney injury prediction. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.26.384

Vancouver

Yun HR, Yoo TH. Who benefits most from clinical artificial intelligence (AI)? Lessons from AI-assisted acute kidney injury prediction. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.26.384

BibTeX
@article{Yun2026,
  author = {Yun, Hae-Ryong and Yoo, Tae-Hyun},
  title = {Who benefits most from clinical artificial intelligence (AI)? Lessons from AI-assisted acute kidney injury prediction},
  journal = {Kidney Research and Clinical Practice},
  year = {2026},
  doi = {10.23876/j.krcp.26.384}
}
Kostenlos starten →